We have looked over some key metrics of Alibaba.
Based on Revenue, Debt, Net Income, PE, Free Cash Flow and other metric we have concluded that Alibaba can continue to move higher.
We provide some baseline targets based off of wall street EPS estimates.
We prove some hyperbolic targets based off of historical median PE targets.
Its amazing how much risk premium is built into this China valuation as Alibaba sure looks good.
EPS is set to continue to surge, Cap Ex spending should slow, net debt has been reducing.
All key metrics support a stronger balance sheet and a continued growth.
Baba cloud division is finally turning profitable and if this continues will be a major tailwind for the stock.
New AI chip development could catapult this stock as it tries to capture a tiny share of NVDA market.
We have been long
BABA since early July and will continue to buy on pullbacks (Not FA advice)
Based on Revenue, Debt, Net Income, PE, Free Cash Flow and other metric we have concluded that Alibaba can continue to move higher.
We provide some baseline targets based off of wall street EPS estimates.
We prove some hyperbolic targets based off of historical median PE targets.
Its amazing how much risk premium is built into this China valuation as Alibaba sure looks good.
EPS is set to continue to surge, Cap Ex spending should slow, net debt has been reducing.
All key metrics support a stronger balance sheet and a continued growth.
Baba cloud division is finally turning profitable and if this continues will be a major tailwind for the stock.
New AI chip development could catapult this stock as it tries to capture a tiny share of NVDA market.
We have been long
BABA since early July and will continue to buy on pullbacks (Not FA advice) 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.